- Activities: Comprehensive Exam 92 (Jan-June 2025 issues) , Comprehensive Exam 91 (July-Dec 2024 issues), 1744, 1743, 1742, 1741, 1740, 1739, 1738, 1737, 1736, 1735, 1734, 1733, 1732, 1731, 1730, 1729, 1728, 1727, 1726, 1725, 1724, 1723, 1722, 1721: Drugs for Irritable Bowel Syndrome, 1720: New Drugs for COPD, Rosacea, Primary Biliary Cholangitis, NSCLC, and more, 1719: Treatment of AMD, New Drugs for Presbyopia, Parkinson's Disease, and Leukemia, Comprehensive Exam 90 (Jan-June 2024 issues), Comprehensive Exam 89 (July-Dec 2023 issues), 1718: New Drugs for Cholangitis, Duchenne Muscular Dystrophy, ADHD, Parkinson s Disease, and ALL, Aspiration with GLP-1 Agonists, 1717: Antivirals for Influenza, A New Drug for Hemophilia A and B, more, 1716: Drugs for Asthma, 1715: New Drugs for Schizophrenia, Atopic Dermatitis, Erectile Dysfunction, Ulcerative Colitis, GVHD, Breast Cancer, more, 1714: Treatment of Hepatitis C, New Drug for NSCLC, more, 1713: New Vaccines for Pneumococcus and RSV, Inhaled Epinephrine, New Drug for GERD, more, 1712: Drugs for Plaque Psoriasis, 1711: Influenza and COVID Vaccines, New Drug for Atopic Dermatitis, 1710: Drugs for COPD, 1709: New drugs for Alzheimer s Disease, COPD, Axillary Hyperhidrosis, Neutropenia, Colorectal Cancer, more, 1708: Drugs for Epilepsy, 1707: New Drugs for Frostbite, Bipolar Disorder, and Complicated UTI, 1706: Drugs for Postmenopausal Osteoporosis, 1705: New Drugs for Depression, Blepharitis, Mydriasis, and Candidemia, 1704: Treatment of Head Lice, New Drugs for Hypertension, Eosinophilic Esophagitis, Hemophilia B, and Pediatric Glioma, 1703: A Review of Drugs for Hypertension, 1702: New drugs for PAH, Polymyalgia Rheumatica, Beta Thalassemia, and COVID-19, 1701: Antibiotic Prophylaxis for Dental Procedures, New Drugs for MASH, Pain, and Glaucoma, 1700: New Drugs for Seborrheic Dermatitis, Acne, and Myasthenia Gravis, Islet Transplant for Type I Diabetes, 1699: Treatment of Bipolar Disorder, New Drug for Food Allergies, 1698: New Drugs for Asthma and Ulcerative Colitis, New Meningococcal Vaccine, 1697: Treatment of Menopausal Symptoms, New Drug for Hyperphosphatemia, Prolia Warning, 1696: New Drugs for Anemia of Chronic Kidney Disease, Molluscum Contagiosum, Myasthenia Gravis, and Warfarin Reversal
- Provider Ship: 1
- Provider Address: New Rochelle, NY, USA
- Activity Link: http://www.medicalletter.org
- Number of Activities Reported Last Year: 80
- Name of Contact: Jean-Marie Pflomm
- Phone Number: (914) 235-0500
- Address: 145 Huguenot Street, Suite 312, New Rochelle, NY, 10801, USA
- Accreditation Status: Accreditation
- Accredited Provider: ACCME
- Activity Format: Enduring Material
Deprecated: File Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /nas/content/live/sleepliteracy/wp-includes/functions.php on line 6121
Leave a Reply